Insider Trading: Biomarin Pharmaceutical Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by
insiders of Biomarin Pharmaceutical Inc since year 2005 are given in the first table.
The second table lists detailed insider transactions reported by Biomarin Pharmaceutical Inc since 2005.
The reporting company's ticker symbol is BMRN .
The reporting company's CIK number is 1048477 .
The total value of stock buying during this period is $646,308.
The total value of stock sales is $47,956,809.
The total value of stock exercises is $11,396,201.
Figure 1. Monthly insider transaction values at Biomarin Pharmaceutical Inc (BMRN) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
06
07
08
09
10
11
12
01 2007
02
03
04
05
06
07
08
09
10
11
12
01 2008
02
03
04
05
Figure 2. Average prices of insider buys, sales, and option exercises at Biomarin Pharmaceutical Inc (BMRN) in the past 24 months. See table 2 for insider transaction details.
06
07
08
09
10
11
12
01 2007
02
03
04
05
06
07
08
09
10
11
12
01 2008
02
03
04
05
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Biomarin Pharmaceutical Inc (BMRN ).
Trading Period
Insider Buying
Insider Sales
Option Exercises
2008-05 0 0 88,553 3,357,035 81,105 570,981 2008-04 7,025 72,847 115,479 4,207,105 153,057 799,223 2008-03 0 0 489,028 17,346,926 397,956 3,672,988 2008-02 0 0 147,462 5,573,043 118,625 1,063,920 2008-01 0 0 35,490 1,282,515 35,490 245,758 2007-12 0 0 21,114 753,555 21,114 171,399 2007-11 0 0 2,365 61,052 2,365 26,383 2007-10 4,695 32,483 51,371 1,319,926 51,371 450,827 2007-09 0 0 238,442 5,460,865 171,149 1,143,929 2007-08 0 0 127,019 2,584,412 135,019 945,200 2007-07 0 0 14,500 263,830 12,500 50,000 2007-06 0 0 16,045 291,737 11,045 73,043 2007-05 0 0 18,500 313,563 15,000 96,900 2007-04 12,892 74,852 19,000 332,357 17,500 82,300 2007-03 0 0 13,500 221,188 0 0 2007-02 0 0 42,000 777,821 28,000 187,090 2007-01 0 0 12,500 203,700 12,500 50,000 2006-12 2,100 37,555 14,500 261,000 14,500 117,450 2006-11 0 0 17,500 285,125 17,500 85,800 2006-10 12,893 60,411 0 0 0 0 2006-08 2,500 37,100 98,500 1,526,147 128,500 929,790 2006-07 1,500 21,659 0 0 20,000 94,400 2006-06 1,500 19,575 0 0 0 0 2006-05 5,500 67,658 0 0 0 0 2006-04 1,500 20,010 0 0 0 0 2006-03 1,500 19,489 28,000 391,000 28,000 188,670 2006-02 5,000 62,941 23,500 286,280 23,500 132,650 2006-01 1,500 16,177 2,500 30,500 52,500 217,500 2005-12 2,500 25,145 40,571 420,417 0 0 2005-11 1,500 12,554 40,571 405,710 0 0 2005-10 3,500 27,265 0 0 0 0 2005-09 4,500 38,587 0 0 0 0
Table 2. Detailed insider stock purchases, sales, and option exercises
for Biomarin Pharmaceutical Inc (BMRN )
Trade Date
Insider Name
Trade Type
Shares
Price ($)
Value ($)
2008-05-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 39.10 195,524 2008-05-15 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 5,000 6.46 32,300 2008-05-13 Davis George Eric (VP, General Counsel) Sale 10,000 39.15 391,520 2008-05-13 Davis George Eric (VP, General Counsel) Option Exercise 10,000 11.74 117,400 2008-05-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 39.18 195,891 2008-05-12 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 5,000 6.46 32,300 2008-05-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 39.04 312,320 2008-05-09 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 8,000 6.46 51,680 2008-05-06 Aselage Steve (SVP, Global Commercial Dev.) Sale 16,200 37.75 611,550 2008-05-06 Aselage Steve (SVP, Global Commercial Dev.) Option Exercise 12,205 9.45 115,337 2008-05-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 36.56 182,775 2008-05-05 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 5,000 6.46 32,300 2008-05-02 Aselage Steve (SVP, Global Commercial Dev.) Sale 3,800 37.75 143,450 2008-05-02 Aselage Steve (SVP, Global Commercial Dev.) Option Exercise 2,900 7.16 20,764 2008-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,100 36.87 372,387 2008-05-02 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 10,000 6.46 64,600 2008-05-01 Kakkis Emil D (Chief Medical Officer) Sale 18,000 37.46 674,271 2008-05-01 Kakkis Emil D (Chief Medical Officer) Option Exercise 18,000 4.00 72,000 2008-05-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 7,453 37.21 277,347 2008-05-01 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 5,000 6.46 32,300 2008-04-30 Davis George Eric (VP, General Counsel) Purchase 1,810 10.37 18,769 2008-04-30 Davis George Eric (VP, General Counsel) Sale 5,000 36.51 181,628 2008-04-30 Davis George Eric (VP, General Counsel) Option Exercise 5,000 7.84 39,200 2008-04-30 Kakkis Emil D (Chief Medical Officer) Purchase 1,640 10.37 17,006 2008-04-30 Aselage Steve (SVP, Global Commercial Dev.) Purchase 1,526 10.37 15,824 2008-04-30 Bienaime Jean Jacques (Chief Executive Officer) Purchase 2,049 10.37 21,248 2008-04-29 Kakkis Emil D (Chief Medical Officer) Option Exercise 75,000 4.00 300,000 2008-04-21 Wood Mark (VP, Human Resources) Sale 2,990 33.99 101,620 2008-04-21 Wood Mark (VP, Human Resources) Option Exercise 2,990 12.18 36,433 2008-04-02 Baffi Robert (SVP, Technical Operations) Sale 38,762 36.99 1,432,900 2008-04-02 Baffi Robert (SVP, Technical Operations) Option Exercise 38,762 6.94 269,202 2008-04-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 35.95 449,403 2008-04-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Exercise 12,500 6.13 76,625 2008-04-01 Kakkis Emil D (Chief Medical Officer) Sale 18,000 35.84 645,197 2008-04-01 Kakkis Emil D (Chief Medical Officer) Option Exercise 18,000 4.00 72,000 2008-04-01 Aselage Steve (SVP, Global Commercial Dev) Sale 805 35.98 28,963 2008-04-01 Aselage Steve (SVP, Global Commercial Dev) Option Exercise 805 7.16 5,763 2008-03-25 Baffi Robert (SVP, Technical Operations) Sale 34,998 35.87 1,256,122 2008-03-25 Baffi Robert (SVP, Technical Operations) Option Exercise 34,998 9.93 347,530 2008-03-24 Wood Mark (VP, Human Resources) Sale 2,989 35.05 104,758 2008-03-24 Wood Mark (VP, Human Resources) Option Exercise 2,989 12.18 36,420 2008-03-18 Baffi Robert (SVP, Technical Operations) Sale 46,240 32.44 1,498,446 2008-03-18 Baffi Robert (SVP, Technical Operations) Option Exercise 46,240 12.10 559,504 2008-03-14 Baffi Robert (SVP, Technical Operations) Sale 76,486 33.11 2,556,404 2008-03-14 Baffi Robert (SVP, Technical Operations) Option Exercise 76,486 9.50 726,616 2008-03-06 Kakkis Emil D (Chief Medical Officer) Sale 18,000 38.15 686,622 2008-03-06 Kakkis Emil D (Chief Medical Officer) Option Exercise 18,000 4.00 72,000 2008-03-06 Heron Elaine J (Director) Sale 30,000 37.95 1,139,699 2008-03-06 Heron Elaine J (Director) Option Exercise 60,000 7.75 465,000 2008-03-05 Grey Michael G (Director) Sale 25,000 38.31 955,569 2008-03-05 Grey Michael G (Director) Option Exercise 30,000 10.33 309,900 2008-03-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 38.00 152,000 2008-03-04 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 4,000 6.46 25,840 2008-03-03 Davis George Eric (VP, General Counsel) Sale 20,000 38.00 760,000 2008-03-03 Davis George Eric (VP, General Counsel) Option Exercise 20,000 6.98 139,700 2008-03-03 Heron Elaine J (Director) Sale 20,000 38.47 769,400 2008-03-03 Aselage Steve (SVP, Global Commercial Dev) Sale 40,000 38.00 1,520,000 2008-03-03 Aselage Steve (SVP, Global Commercial Dev) Option Exercise 65,000 9.45 614,250 2008-03-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 38.13 76,263 2008-03-03 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 2,000 6.46 12,920 2008-03-03 Klein Joseph Iii (Director) Sale 10,000 38.06 380,550 2008-02-29 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 55,625 37.81 2,096,682 2008-02-29 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Exercise 55,625 7.78 432,540 2008-02-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 21,142 38.11 805,705 2008-02-29 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 18,000 6.46 116,280 2008-02-29 Klein Joseph Iii (Director) Option Exercise 30,000 14.21 426,300 2008-02-29 Lapalme Pierre (Director) Sale 15,000 38.02 569,544 2008-02-29 Lapalme Pierre (Director) Option Exercise 15,000 5.92 88,800 2008-01-22 Wood Mark (VP, Human Resources) Sale 2,990 36.31 108,575 2008-01-22 Wood Mark (VP, Human Resources) Option Exercise 2,990 12.18 36,433 2008-01-02 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 36.16 452,045 2008-01-02 Swiedler Stuart J (SVP, Clinical Affairs) Option Exercise 12,500 6.13 76,625 2008-01-02 Aselage Steve (SVP, Global Commercial Dev) Sale 5,000 36.10 180,475 2008-01-02 Aselage Steve (SVP, Global Commercial Dev) Option Exercise 5,000 7.16 35,800 2008-01-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 36.09 541,420 2008-01-02 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 15,000 6.46 96,900 2007-12-21 Wood Mark (VP, Human Resources) Sale 6,114 36.08 220,562 2007-12-21 Wood Mark (VP, Human Resources) Option Exercise 6,114 12.18 74,499 2007-12-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 35.53 532,993 2007-12-17 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 15,000 6.46 96,900 2007-11-21 Wood Mark (VP, Human Resources) Sale 2,365 25.82 61,052 2007-11-21 Wood Mark (VP, Human Resources) Option Exercise 2,365 11.16 26,383 2007-10-31 Kakkis Emil D (Chief Medical Officer) Purchase 2,038 6.92 14,100 2007-10-31 Aselage Steve (SVP, Global Commercial Dev) Purchase 2,139 6.92 14,799 2007-10-31 Bienaime Jean Jacques (Chief Executive Officer) Purchase 518 6.92 3,584 2007-10-24 Wood Mark (VP, Human Resources) Sale 833 26.00 21,658 2007-10-24 Wood Mark (VP, Human Resources) Option Exercise 833 17.54 14,610 2007-10-22 Wood Mark (VP, Human Resources) Sale 1,532 25.30 38,761 2007-10-22 Wood Mark (VP, Human Resources) Option Exercise 1,532 9.56 14,645 2007-10-11 Davis George Eric (VP, General Counsel) Sale 5,000 27.34 136,700 2007-10-11 Davis George Eric (VP, General Counsel) Option Exercise 5,000 8.05 40,250 2007-10-08 Wood Mark (VP, Human Resources) Sale 8,333 26.00 216,658 2007-10-08 Wood Mark (VP, Human Resources) Option Exercise 8,333 17.54 146,160 2007-10-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 12,380 26.00 321,880 2007-10-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Exercise 12,380 8.10 100,278 2007-10-01 Davis George Eric (VP, General Counsel) Sale 5,000 25.10 125,500 2007-10-01 Davis George Eric (VP, General Counsel) Option Exercise 5,000 6.13 30,650 2007-10-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 25.07 313,411 2007-10-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Exercise 12,500 5.06 63,312 2007-10-01 Aselage Steve (SVP, Global Commercial Dev) Sale 5,000 25.09 125,454 2007-10-01 Aselage Steve (SVP, Global Commercial Dev) Option Exercise 5,000 7.16 35,800 2007-10-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 793 25.10 19,904 2007-10-01 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 793 6.46 5,122 2007-09-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 19,207 25.00 480,175 2007-09-28 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 19,207 6.46 124,077 2007-09-26 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 12,500 24.50 306,250 2007-09-26 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Exercise 12,500 8.10 101,250 2007-09-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 24.00 240,000 2007-09-25 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 10,000 6.46 64,600 2007-09-21 Wood Mark (VP, Human Resources) Sale 5,906 23.24 137,266 2007-09-21 Wood Mark (VP, Human Resources) Option Exercise 5,906 9.56 56,461 2007-09-19 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 23.00 230,000 2007-09-19 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 10,000 6.46 64,600 2007-09-14 Baffi Robert (SVP, Technical Operations) Sale 90,000 22.57 2,026,634 2007-09-14 Baffi Robert (SVP, Technical Operations) Option Exercise 90,000 6.13 551,700 2007-09-14 Aselage Steve (SVP, Global Commercial Dev.) Sale 10,000 22.40 224,000 2007-09-14 Aselage Steve (SVP, Global Commercial Dev.) Option Exercise 10,000 7.16 71,600 2007-09-06 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 13,536 22.50 304,560 2007-09-06 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Exercise 13,536 8.10 109,641 2007-08-17 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 20,000 20.28 405,658 2007-08-17 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Exercise 20,000 6.35 126,933 2007-08-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 21.00 210,000 2007-08-17 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 10,000 6.46 64,600 2007-08-15 Davis George Eric (VP, General Counsel) Sale 4,000 20.26 81,040 2007-08-15 Davis George Eric (VP, General Counsel) Option Exercise 4,000 6.13 24,520 2007-08-10 Wood Mark (VP, Human Resources) Sale 2,633 21.08 55,503 2007-08-10 Wood Mark (VP, Human Resources) Option Exercise 2,633 8.08 21,274 2007-08-10 Aselage Steve (SVP, Global Commercial Dev) Sale 20,000 20.29 405,893 2007-08-10 Aselage Steve (SVP, Global Commercial Dev) Option Exercise 20,000 7.16 143,200 2007-08-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 35,886 20.20 725,076 2007-08-10 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 35,886 6.46 231,823 2007-08-10 Lewis Alan (Director) Sale 20,000 20.13 402,694 2007-08-10 Lewis Alan (Director) Option Exercise 30,000 7.72 231,600 2007-08-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 12,500 21.00 262,500 2007-08-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Exercise 12,500 8.10 101,250 2007-08-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 18.02 36,048 2007-07-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 18.28 36,569 2007-07-02 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 18.18 227,261 2007-07-02 Swiedler Stuart J (SVP, Clinical Affairs) Option Exercise 12,500 4.00 50,000 2007-06-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,500 17.65 44,125 2007-06-07 Wood Mark (VP, Human Resources) Sale 1,045 17.54 18,332 2007-06-07 Wood Mark (VP, Human Resources) Option Exercise 1,045 8.08 8,443 2007-06-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,500 18.39 45,975 2007-06-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 18.33 183,305 2007-06-01 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 10,000 6.46 64,600 2007-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 18.56 37,121 2007-05-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 16.79 251,796 2007-05-03 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 15,000 6.46 96,900 2007-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 16.43 24,646 2007-04-30 Davis George Eric (VP, General Counsel) Purchase 2,607 5.18 13,517 2007-04-30 Baffi Robert (SVP, Technical Operations) Purchase 2,684 5.18 13,916 2007-04-30 Kakkis Emil D (Chief Medical Officer) Purchase 2,982 5.18 15,461 2007-04-30 Aselage Steve (SVP, Global Commercial Dev) Purchase 2,066 6.92 14,294 2007-04-30 Bienaime Jean Jacques (Chief Executive Officer) Purchase 2,553 6.92 17,664 2007-04-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 6,500 17.86 116,116 2007-04-04 Bienaime Jean Jacques (Chief Executive Officer) Option Exercise 5,000 6.46 32,300 2007-04-02 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 17.30 216,241 2007-04-02 Swiedler Stuart J (SVP, Clinical Affairs) Option Exercise 12,500 4.00 50,000 2007-03-07 Klein Joseph Iii (Director) Sale 12,000 16.37 196,464 2007-03-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 16.48 24,724 2007-02-22 Davis George Eric (VP, General Counsel) Sale 13,000 18.38 238,940 2007-02-22 Davis George Eric (VP, General Counsel) Option Exercise 13,000 6.13 79,690 2007-02-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 18.40 18,400 2007-02-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 13,000 16.96 220,481 2007-02-14 Aselage Steve (SVP, Global Commercial Ops) Sale 15,000 20.00 300,000 2007-02-14 Aselage Steve (SVP, Global Commercial Ops) Option Exercise 15,000 7.16 107,400 2007-01-03 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 16.30 203,700 2007-01-03 Swiedler Stuart J (SVP, Clinical Affairs) Option Exercise 12,500 4.00 50,000 2006-12-12 Lapalme Pierre (Director) Purchase 2,100 17.88 37,555 2006-12-06 Cooper Jeffrey H (Chief Financial Officer) Sale 14,500 18.00 261,000 2006-12-06 Cooper Jeffrey H (Chief Financial Officer) Option Exercise 14,500 8.10 117,450 2006-11-29 Aselage Steve (SVP, Global Commercial Ops) Sale 5,000 17.23 86,150 2006-11-29 Aselage Steve (SVP, Global Commercial Ops) Option Exercise 5,000 7.16 35,800 2006-11-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 15.92 198,975 2006-11-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Exercise 12,500 4.00 50,000 2006-10-31 Baffi Robert (SVP, Technical Operations) Purchase 3,894 3.43 13,371 2006-10-31 Kakkis Emil D (Chief Medical Officer) Purchase 4,368 3.43 14,999 2006-10-31 Aselage Steve (SVP, Global Commercial Ops) Purchase 1,870 6.92 12,938 2006-10-31 Bienaime Jean Jacques (Chief Executive Officer) Purchase 2,761 6.92 19,103 2006-08-29 Cooper Jeffrey H (VP, Chief Financial Officer) Sale 26,000 16.00 416,000 2006-08-29 Cooper Jeffrey H (VP, Chief Financial Officer) Option Exercise 26,000 7.12 184,990 2006-08-09 Klein Joseph Iii (Director) Sale 40,000 15.52 620,640 2006-08-09 Klein Joseph Iii (Director) Option Exercise 60,000 7.72 463,200 2006-08-07 Lapalme Pierre (Director) Purchase 1,000 15.35 15,350 2006-08-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 14.34 179,187 2006-08-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Exercise 12,500 4.00 50,000 2006-08-01 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 14.50 21,750 2006-07-19 Heron Elaine J (Director) Option Exercise 20,000 4.72 94,400 2006-07-03 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 14.44 21,659 2006-06-01 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 13.05 19,575 2006-05-18 Bienaime Jean Jacques (Chief Executive Officer) Purchase 2,000 12.00 24,000 2006-05-08 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,000 12.78 12,778 2006-05-01 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 12.59 18,880 2006-04-03 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 13.34 20,010 2006-03-16 Cooper Jeffrey H (Chief Financial Officer) Sale 12,500 14.85 185,625 2006-03-16 Cooper Jeffrey H (Chief Financial Officer) Option Exercise 12,500 8.10 101,250 2006-03-01 Cooper Jeffrey H (Chief Financial Officer) Sale 15,500 13.25 205,375 2006-03-01 Cooper Jeffrey H (Chief Financial Officer) Option Exercise 15,500 5.64 87,420 2006-03-01 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 12.99 19,489 2006-02-27 Cooper Jeffrey H (Chief Financial Officer) Sale 1,000 13.25 13,250 2006-02-27 Cooper Jeffrey H (Chief Financial Officer) Option Exercise 1,000 5.15 5,150 2006-02-27 Lapalme Pierre (Director) Purchase 3,500 12.98 45,441 2006-02-24 Sager Erich (Director) Sale 11,500 12.64 145,360 2006-02-24 Sager Erich (Director) Option Exercise 11,500 7.00 80,500 2006-02-22 Sager Erich (Director) Sale 1,000 12.20 12,200 2006-02-22 Sager Erich (Director) Option Exercise 1,000 7.00 7,000 2006-02-01 Swiedler Stuart J (SVP, Clinical Affair) Sale 10,000 11.55 115,470 2006-02-01 Swiedler Stuart J (SVP, Clinical Affair) Option Exercise 10,000 4.00 40,000 2006-02-01 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 11.67 17,500 2006-01-27 Sager Erich (Director) Sale 2,500 12.20 30,500 2006-01-27 Sager Erich (Director) Option Exercise 2,500 7.00 17,500 2006-01-04 Kakkis Emil D (Chief Medical Officer) Option Exercise 50,000 4.00 200,000 2006-01-03 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 10.78 16,177 2005-12-12 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,000 10.21 10,208 2005-12-05 Sager Erich (Director) Sale 7,500 10.70 80,257 2005-12-01 Sager Erich (Director) Sale 22,500 10.42 234,450 2005-12-01 Starr Christopher M (SVP, Chief Scientifi) Sale 10,571 10.00 105,710 2005-12-01 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 9.96 14,937 2005-11-21 Swiedler Stuart J (SVP, Clinical Affair) Sale 30,000 10.00 300,000 2005-11-21 Starr Christopher M (SVP, Chief Scientifi) Sale 10,571 10.00 105,710 2005-11-01 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 8.37 12,554 2005-10-12 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,000 7.00 7,000 2005-10-06 Bienaime Jean Jacques (Chief Executive Officer) Purchase 500 8.00 4,000 2005-10-03 Bienaime Jean Jacques (Chief Executive Officer) Purchase 1,500 8.51 12,765 2005-09-01 Bienaime Jean Jacques (Chief Executive Officer) Purchase 4,500 8.58 38,587
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN ,
CIK number 1048477 ) see
the Securities and Exchange Commission (SEC) website.
